लोड हो रहा है...
Pathways to Endocrine Therapy Resistance in Breast Cancer
Breast cancers with positive expression of Estrogen Receptor (ER+) are treated with anti-hormone/endocrine therapy which targets the activity of the receptor, the half-life of the receptor or the availability of estrogen. This has significantly decreased mortality in women with ER+ breast cancer, ho...
में बचाया:
| में प्रकाशित: | Front Endocrinol (Lausanne) |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Frontiers Media S.A.
2019
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6712962/ https://ncbi.nlm.nih.gov/pubmed/31496995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2019.00573 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|